ACTG Launches Second HIV Cure Trial in Africa
The AIDS Clinical Trials Group (ACTG) launched the ACACIA study, a Phase 2 trial investigating the use of two...
eClinical Tech News
RS Biotherapeutics Sees Positive Effects of Lead Compound on Human Lung Tissue
RS BioTherapeutics announced positive results from a human lung tissue study of its lead compound, RSBT-001. The study showed...
Humacyte Plans IND Filing for Small-Diameter ATEV™ in 2025
Humacyte plans to submit an Investigational New Drug (IND) application to the FDA for its small-diameter (3.5mm) acellular tissue...
AI in Oncology to Hit $11.52B by 2030, with 29.4% CAGR
The global AI in oncology market, valued at US$1.92 billion in 2023, is projected to reach US$11.52 billion by...
Africa CDC-Led Mpox Therapeutic Study Begins Enrollment
The first patients have been enrolled in the MOSA trial, a pivotal clinical trial evaluating treatments for Mpox (formerly...
Complete 12-Week Results of NORSE Eight Trial for Outlook Therapeutics®
Outlook Therapeutics announced positive 12-week results from its NORSE EIGHT trial for ONS-5010, an ophthalmic bevacizumab formulation for wet...
Solid Biosciences: Advancing Neuromuscular and Cardiac Gene Therapy
Solid Biosciences provided a corporate update highlighting its expanded clinical pipeline and 2025 objectives, focusing on genetic medicines for...
SIL-204 Shows Synergy with Chemotherapies in Preclinical Pancreatic Cancer Study
Silexion Therapeutics (NASDAQ: SLXN) announced promising preclinical results for SIL-204, its second-generation siRNA therapy targeting KRAS-mutated cancers. The data...
Context Therapeutics CTIM-76 Dosed in First Patient of Phase 1 Trial
Context Therapeutics has dosed the first patient in a Phase 1 clinical trial for CTIM-76, a T cell engager...
First Participants Randomized in AskBio Phase II Gene Therapy Trial for Parkinson’s Disease
AskBio, a Bayer subsidiary, has initiated a Phase II clinical trial, REGENERATE-PD, for its Parkinson’s disease gene therapy, AB-1005...